Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Cape Aloe resin is the bitter dried leaf exudate of Aloe ferox, rich in anthraquinones (aloin, aloe-emodin, and aloesin) that stimulate colonic motility for laxative effects and exhibit synergistic growth-inhibiting activity against Ehrlich ascites tumor cells (PMID 17485848). Its polysaccharides and flavonoids additionally promote wound healing by enhancing epidermal keratinocyte proliferation and differentiation (PMID 27736988), while its anti-inflammatory properties are documented in South African ethnobotanical traditions for pain and inflammatory conditions (PMID 34744737).
Reported Benefits (Provisional)
Origin & History
Cape Aloe (Aloe ferox) is a robust succulent plant native to the arid regions of Southern Africa, specifically South Africa, Namibia, and Zimbabwe. Renowned for its bitter sap and nutrient-dense inner leaf gel, it is a cornerstone in functional nutrition for its potent digestive, detoxifying, and skin-supporting properties.
Research Narrative (Provisional)
Kametani et al. (2007) in Bioscience, Biotechnology, and Biochemistry isolated chemical constituents from Cape Aloe and demonstrated their synergistic growth-inhibiting effects on Ehrlich ascites tumor cells, identifying aloin, aloe-emodin, and related anthraquinones as key bioactive agents (PMID 17485848). Moriyama et al. (2016) in PLoS One showed that Aloe genus extracts exert beneficial effects on wound healing through stimulation of cell proliferation and differentiation of epidermal keratinocytes (PMID 27736988). Hawrelak et al. (2020) conducted a systematic review and meta-analysis in Complementary Therapies in Medicine evaluating Western herbal medicines—including aloe-based preparations—in irritable bowel syndrome treatment, finding supportive but limited evidence for gastrointestinal applications (PMID 31987249). Girreser et al. (2019) in Talanta developed validated NMR-based quality control methods distinguishing Aloe ferox from Aloe barbadensis, enabling precise quantification of aloin and other marker compounds critical for standardized dosing (PMID 31450436).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Anthraquinones: Potent laxative compounds that stimulate bowel motility. - Polysaccharides: Support immune function and skin healing. - Flavonoids: Antioxidants that reduce oxidative stress and inflammation. - Prebiotic Fibers: Nourish the gut microbiome and promote digestive health. - Minerals: Including calcium, magnesium, and potassium, essential for various physiological functions.
Reported Mechanism (Provisional)
Cape Aloe's primary anthraquinone glycoside, aloin (barbaloin), is hydrolyzed by colonic bacteria into aloe-emodin, which stimulates colonic peristalsis by inhibiting Na⁺/K⁺-ATPase and chloride channels in intestinal epithelial cells, increasing water and electrolyte secretion into the lumen. Aloe-emodin triggers cancer cell apoptosis through upregulation of the endoplasmic reticulum stress markers CHOP and caspase-12, while simultaneously inhibiting nucleic acid biosynthesis to block bacterial protein synthesis at therapeutic concentrations. Kametani et al. (2007) demonstrated that Cape Aloe constituents—including aloin, aloe-emodin, and aloesin—act synergistically to inhibit tumor cell growth via combined antioxidant and pro-apoptotic pathways (PMID 17485848). The polysaccharide acemannan component enhances immune function by activating macrophage toll-like receptors (TLR-2/TLR-4) and promoting keratinocyte proliferation through upregulation of epidermal growth factor receptor signaling, as supported by wound healing research (PMID 27736988).
Clinical Narrative (Provisional)
Current evidence for Cape Aloe relies primarily on preclinical in vitro and animal studies rather than human clinical trials. Methanol extracts demonstrate strong antioxidant activity with DPPH IC50 values of 0.086 mg/ml and ABTS IC50 of 0.02 mg/ml in laboratory testing. Animal studies show β-sitosterol at doses ≥500 mg/kg increases VEGF, FLK-1, and laminin expression for enhanced angiogenesis in ischemia models. Well-designed human clinical trials with specific dosing protocols and quantified outcomes are needed to establish therapeutic efficacy and safety profiles.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.